For example, inhibition of the glycolytic activator, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3), normalizes tumor vasculature by tightening endothelial cell junctions [34]. The gene discussed is PFKFB3; the disease is neoplasm.